Fulgent Genetics (FLGT) Acquisitions (2021 - 2026)
Fulgent Genetics' (FLGT) quarterly Acquisitions came in at $55.6 million in Q1 2026, up 1571.97% quarter-over-quarter from -$3.8 million in Q3 2025.
Analysis
Fulgent Genetics (FLGT) Acquisitions (2021 - 2026) Analysis & Trends
Fulgent Genetics has disclosed Acquisitions across 4 years of filings, most recently posting $55.6 million for Q1 2026.
- In Q1 2026, Acquisitions changed N/A year-over-year to $55.6 million; the TTM figure through Jun 2026 stood at $51.8 million (up 48.3% YoY), while the FY2025 annual figure was -$3.8 million, changed N/A from the prior year.
- Acquisitions came in at $55.6 million for Q1 2026 at Fulgent Genetics, up from -$3.8 million in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $55.6 million in Q1 2026 to a low of -$3.8 million in Q3 2025.
- Average Acquisitions over 3 years is $28.9 million, with a median of $34.9 million recorded in 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | - |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | - |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 225.70 Mn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | - |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | - |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | - |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | - |
| 10 | Fulgent Genetics | 596.80 Mn | 334.14 Mn | 25.68 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 55.57 Mn |
| Sep 30, 2025 | -3.78 Mn |
| Dec 31, 2022 | 34.92 Mn |
| Sep 30, 2021 | 43.36 Mn |